Dn B Asset Management As Allovir, Inc. Transaction History

Dn B Asset Management As

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 15, 2021	SELL	$20.81 - $45.5 $625,007 - $1.37 Million	-30,034 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$23.94 - $46.81 $719,013 - $1.41 Million	30,034 New	30,034 $1.15 Million

727K

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $913M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

Stay updated on Dn B Asset Management As with notifications on news.